Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Fiche publication
Date publication
janvier 2019
Journal
Clinical rheumatology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LIOURE Bruno, Pr RUBIO Marie Thérèse , Pr MARTIN Thierry
Tous les auteurs :
Guillaume-Jugnot P, Badoglio M, Labopin M, Terriou L, Yakoub-Agha I, Martin T, Lioure B, Marjanovic Z, Blaise D, Nguyen S, Pugnet G, Huynh A, Deligny C, Seinturier C, Garban F, Swiader L, Bay JO, Braun T, de Latour RP, Rubio MT, Farge D
Lien Pubmed
Résumé
The use of autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease (AD) patients has increased progressively worldwide. We retrospectively analysed the long-term outcome of AHSCT for AD reported to the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Mots clés
Adult patients, Autoimmune disease, Autologous, Haematopoietic stem cell transplantation
Référence
Clin. Rheumatol.. 2019 Jan 21;: